Avicanna Inc. (AVCN.TO)
CAD 0.34
(1.49%)
CAD 0.34
(1.49%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -7.35 Million CAD | 28.8% |
| 2022 | -12.17 Million CAD | 2.49% |
| 2021 | -15.12 Million CAD | 43.03% |
| 2020 | -33.69 Million CAD | 20.14% |
| 2019 | -22.26 Million CAD | -142.15% |
| 2018 | -7.08 Million CAD | -258.17% |
| 2017 | -2.52 Million CAD | -8344.05% |
| 2016 | 328.15 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -384.93 Thousand CAD | 75.1% |
| 2024 Q2 | -1.53 Million CAD | -139.51% |
| 2023 Q4 | -1.97 Million CAD | -87.14% |
| 2023 FY | - CAD | 28.8% |
| 2023 Q3 | -1.05 Million CAD | 29.7% |
| 2023 Q2 | -1.49 Million CAD | 30.7% |
| 2023 Q1 | -2.16 Million CAD | 57.37% |
| 2022 Q1 | -364 Thousand CAD | 85.39% |
| 2022 FY | - CAD | 2.49% |
| 2022 Q4 | -5.07 Million CAD | -138.66% |
| 2022 Q3 | -2.12 Million CAD | 0.03% |
| 2022 Q2 | -2.12 Million CAD | -484.29% |
| 2021 Q2 | -2.53 Million CAD | 2.9% |
| 2021 FY | - CAD | 43.03% |
| 2021 Q1 | -2.6 Million CAD | 62.41% |
| 2021 Q4 | -2.49 Million CAD | -7.91% |
| 2021 Q3 | -2.3 Million CAD | 8.82% |
| 2020 Q3 | -4.7 Million CAD | -13.33% |
| 2020 Q2 | -4.15 Million CAD | -165.85% |
| 2020 FY | - CAD | 20.14% |
| 2020 Q1 | -1.56 Million CAD | 79.03% |
| 2020 Q4 | -6.93 Million CAD | -47.38% |
| 2019 Q4 | -7.44 Million CAD | -27.38% |
| 2019 Q3 | -5.84 Million CAD | -20.47% |
| 2019 FY | - CAD | -142.15% |
| 2019 Q2 | -4.85 Million CAD | -35.61% |
| 2019 Q1 | -3.57 Million CAD | 15.84% |
| 2018 Q2 | -1.41 Million CAD | 42.8% |
| 2018 FY | - CAD | -258.17% |
| 2018 Q4 | -4.25 Million CAD | -120.55% |
| 2018 Q3 | -1.92 Million CAD | -36.01% |
| 2018 Q1 | -2.47 Million CAD | -117.34% |
| 2017 Q4 | -1.14 Million CAD | -26980.41% |
| 2017 FY | - CAD | -8344.05% |
| 2017 Q3 | -4211.00 CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aurora Cannabis Inc. | 20.47 Million CAD | 135.926% |
| Avant Brands Inc. | 4.83 Million CAD | 252.098% |
| Cardiol Therapeutics Inc. | -27.87 Million CAD | 73.617% |
| Crescita Therapeutics Inc. | 45 Thousand CAD | 16445.471% |
| Knight Therapeutics Inc. | 40.89 Million CAD | 117.985% |
| MediPharm Labs Corp. | -10.47 Million CAD | 29.801% |
| OrganiGram Holdings Inc. | -207.61 Million CAD | 96.457% |
| Canopy Growth Corporation | -312.82 Million CAD | 97.649% |
| Willow Biosciences Inc. | -11.06 Million CAD | 33.501% |
| Auxly Cannabis Group Inc. | -10.82 Million CAD | 32.051% |